| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT06823713 | RTX001 Autologous Engineered Macrophages for Liver Cirrhosis | End-stage Liver Disease (ESLD) | Active, Not Recruiting | 2026-10-05 |
| Not specified | ||||
| NCT06380335 | Study in Patients With Decompensated Liver Cirrhosis | Liver Cirrhosis | Active, Not Recruiting | 2026-01-29 |